Salkind Gene — SEC Form 4 filings
SEC reporting owner CIK 1592481. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-20.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-09 to 2026-07-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 5 filings — 523,072 shares, $1,331,507 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: purchase of 241,229 shares @ $2.28 ($550,002) in UPEXI, INC., filed 2025-04-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UPEXI, INC. (UPXI) | Director | 5 | 5 legs · 511,472 sh · $1,323,503 | — | 5 |
| Coeptis Therapeutics Holdings, Inc. (COEP) | Director | 3 | 1 leg · 11,600 sh · $8,004 | — | 3 |
| Mobiquity Technologies, Inc. (MOBQ) | Director, 10% owner | 8 | — | — | 12 |
Form 4 filings — Salkind Gene
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-20 | 4 | UPEXI, INC. (UPXI) | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-02-13 | 4 | Coeptis Therapeutics Holdings, Inc. (COEP) | Option exercise (M): 5,700 @ $10.56 · Grant/award (A): 3,250 @ $0 | EDGAR |
| 2026-01-02 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Grant/award (A): 250,000 (derivative) | EDGAR |
| 2025-11-21 | 4 | UPEXI, INC. (UPXI) | Purchase (P): 50,000 @ $2.55 | EDGAR |
| 2025-11-18 | 4 | UPEXI, INC. (UPXI) | Purchase (P): 100,000 @ $2.65 · Purchase (P): 100,000 @ $2.81 | EDGAR |
| 2025-09-19 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Grant/award (A): 25,000 @ $1 · Grant/award (A): 100,000 (derivative) | EDGAR |
| 2025-07-30 | 4 | UPEXI, INC. (UPXI) | Purchase (P): 20,243 @ $4.94 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-04-25 | 4 | UPEXI, INC. (UPXI) | Purchase (P): 241,229 @ $2.28 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Coeptis Therapeutics Holdings, Inc. (COEP) | Grant/award (A): 5,700 (derivative) | EDGAR |
| 2025-01-02 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Option exercise/expiry (X): 420,000 @ $0.50 · Option exercise/expiry (X): 210,000 (derivative) | EDGAR |
| 2024-10-21 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Grant/award (A): 250,000 (derivative) | EDGAR |
| 2024-08-22 | 4/A | Mobiquity Technologies, Inc. (MOBQ) | Conversion (C): 7,675,160 @ $0.20 · Conversion (C): 751,973 (derivative) | EDGAR |
| 2024-08-08 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Conversion (C): 7,675,160 @ $0.20 · Conversion (C): 751,973 (derivative) | EDGAR |
| 2024-07-29 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Grant/award (A): 50,000 (derivative) | EDGAR |
| 2024-07-01 | 4 | Mobiquity Technologies, Inc. (MOBQ) | Grant/award (A): 160,000 (derivative) | EDGAR |
| 2024-01-09 | 4 | Coeptis Therapeutics Holdings, Inc. (COEP) | Purchase (P): 11,600 @ $0.69 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1592481 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →